|
TRNT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.050200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.403600E-01 |
| Normal-vs-Stage2 |
2.834600E-01 |
| Normal-vs-Stage3 |
2.151600E-01 |
| Normal-vs-Stage4 |
2.277600E-02 |
| Stage1-vs-Stage2 |
5.507600E-01 |
| Stage1-vs-Stage3 |
3.955400E-01 |
| Stage1-vs-Stage4 |
7.163000E-03 |
| Stage2-vs-Stage3 |
9.014600E-01 |
| Stage2-vs-Stage4 |
1.941600E-01 |
| Stage3-vs-Stage4 |
1.478560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.049400E-01 |
| Normal-vs-AfricanAmerican |
9.067700E-02 |
| Normal-vs-Asian |
4.687600E-01 |
| Caucasian-vs-AfricanAmerican |
6.806100E-02 |
| Caucasian-vs-Asian |
6.038400E-01 |
| AfricanAmerican-vs-Asian |
9.015600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.280200E-01 |
| Normal-vs-Female |
8.529200E-01 |
| Male-vs-Female |
9.375800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.958200E-02 |
| Normal-vs-Extreme_Weight |
2.806800E-01 |
| Normal-vs-Obese |
5.807400E-01 |
| Normal-vs-Extreme_Obese |
6.815200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.848000E-01 |
| Normal_Weight-vs-Obese |
1.887370E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.592600E-01 |
| Extreme_Weight-vs-Obese |
5.547800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.054800E-01 |
| Obese-vs-Extreme_Obese |
9.546800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.004000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.949400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.331600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.671360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.091600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.534800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.704950E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.937600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.133400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.756800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.718800E-01 |
| Normal-VS-Type2 PRCC |
1.557400E-01 |
| Normal-VS-KIRP CIMP |
6.410200E-01 |
| Normal-VS-Unclassified PRCC |
5.990600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.189900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.429600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.055400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.822200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.927600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.305800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.972300E-02 |
| Normal-vs-N1 |
2.706000E-01 |
| Normal-vs-N2 |
8.725900E-02 |
| N0-vs-N1 |
5.911000E-01 |
| N0-vs-N2 |
3.329000E-01 |
| N1-vs-N2 |
2.313400E-01 |
|
|
